bioMerieux SA (BIM):企業の財務・戦略的SWOT分析

◆英語タイトル:bioMerieux SA (BIM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME643FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:67
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥49,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

bioMerieux SA (BIM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures, and markets in vitro diagnostic solutions for hospital and private laboratories. The company offers diagnostic solutions such as systems, reagents, and software for the diagnosis of infectious diseases, cardiovascular diseases, and cancers and identifying microorganisms in pharmaceuticals, cosmetics, and agri-food products. It offers microbiology products, immunoassays, molecular biology tests, and other solutions for clinical applications and industrial microbiological control solutions for the food, biopharmaceutical and cosmetics industries; veterinary diagnostic laboratories; and blood banks. bioMerieux also provides solutions for the enumeration of bacterial flora which indicate the quality of food products. The company distributes its products directly and also through a network of distributors across the world. bioMerieux is headquartered in Marcy l’Etoile, France.

bioMerieux SA Key Recent Developments

Feb 24,2021: bioMerieux – 2020 financial results
Dec 14,2020: BioMerieux – Increased outlook for full-year 2020
Oct 22,2020: bioMérieux – third-quarter 2020 business review
Oct 08,2020: AMSP partners with bioMérieux to facilitate supply of high-quality COVID-19 diagnostics
Sep 30,2020: Johnson & Johnson joins other companies in signing a landmark Communiqué on expanded global access for COVID-19

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
bioMerieux SA – Key Facts
bioMerieux SA – Key Employees
bioMerieux SA – Key Employee Biographies
bioMerieux SA – Major Products and Services
bioMerieux SA – History
bioMerieux SA – Company Statement
bioMerieux SA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
bioMerieux SA – Business Description
Business Segment: Clinical Applications
Overview
Performance
Business Segment: Industrial Applications
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe, Middle East, and Africa
Performance
R&D Overview
bioMerieux SA – Corporate Strategy
bioMerieux SA – SWOT Analysis
SWOT Analysis – Overview
bioMerieux SA – Strengths
bioMerieux SA – Weaknesses
bioMerieux SA – Opportunities
bioMerieux SA – Threats
bioMerieux SA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
bioMerieux SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
bioMerieux SA, Medical Equipment, Deals By Type, 2015 to YTD 2021
bioMerieux SA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 24, 2021: bioMerieux – 2020 financial results
Dec 14, 2020: BioMerieux – Increased outlook for full-year 2020
Oct 22, 2020: bioMérieux – third-quarter 2020 business review
Oct 08, 2020: AMSP partners with bioMérieux to facilitate supply of high-quality COVID-19 diagnostics
Sep 30, 2020: Johnson & Johnson joins other companies in signing a landmark Communiqué on expanded global access for COVID-19
Jul 09, 2020: bioMérieux – Second quarter 2020 business performance preannouncement
Jun 02, 2020: Teklynx labeling software teklynx central increases labeling accuracy & compliance by 100% for global biotechnology company bioMerieux
Apr 16, 2020: bioMérieux first-quarter 2020 business review
Mar 27, 2020: Novartis partners with life sciences companies to fight Covid-19
Mar 26, 2020: Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
bioMerieux SA, Key Facts
bioMerieux SA, Key Employees
bioMerieux SA, Key Employee Biographies
bioMerieux SA, Major Products and Services
bioMerieux SA, History
bioMerieux SA, Subsidiaries
bioMerieux SA, Key Competitors
bioMerieux SA, Ratios based on current share price
bioMerieux SA, Annual Ratios
bioMerieux SA, Annual Ratios (Cont...1)
bioMerieux SA, Annual Ratios (Cont...2)
bioMerieux SA, Interim Ratios
bioMerieux SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
bioMerieux SA, Medical Equipment, Deals By Type, 2015 to YTD 2021
bioMerieux SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[bioMerieux SA (BIM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bank Of Ireland (Uk) Plc:企業の戦略・SWOT・財務分析
    Bank Of Ireland (Uk) Plc - Strategy, SWOT and Corporate Finance Report Summary Bank Of Ireland (Uk) Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kuros Biosciences AG (KURN):企業の財務・戦略的SWOT分析
    Kuros Biosciences AG (KURN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Tri-County Rural Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Tri-County Rural Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • St. George’s University of London:製薬・医療:M&Aディール及び事業提携情報
    Summary St. George's University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider. It offers undergraduate and post graduate courses. The university’s undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthca …
  • Guangzhou R&F Properties Co Ltd:企業の戦略・SWOT・財務情報
    Guangzhou R&F Properties Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Guangzhou R&F Properties Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • VidaCaixa, S.A.U. de Seguros y Reaseguros:企業の戦略・SWOT・財務情報
    VidaCaixa, S.A.U. de Seguros y Reaseguros - Strategy, SWOT and Corporate Finance Report Summary VidaCaixa, S.A.U. de Seguros y Reaseguros - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Balaji Amines Ltd (BALAMINES):企業の財務・戦略的SWOT分析
    Balaji Amines Ltd (BALAMINES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Rockwell Medical Inc (RMTI):医療機器:M&Aディール及び事業提携情報
    Summary Rockwell Medical Inc (Rockwell) is a biopharmaceutical company that focuses on the development, manufacture and distribution of products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The company’s major products include Triferic, an iron d …
  • Absa Bank Ltd
    Absa Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Absa Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Armetheon Inc-製薬・医療分野:企業M&A・提携分析
    Summary Armetheon Inc (Armetheon) is a drug development company that develops novel small molecule drugs for treatment of cardiovascular diseases with high unmet medical need. The company develops anticoagulants and antibiotics that make use of the antibiotic resistance mechanisms to provide bacteri …
  • Johnson & Johnson (JNJ)-製薬・医療分野:企業M&A・提携分析
    Summary Johnson & Johnson (J&J) engages in the research and development, manufacture and sale of a range of healthcare products. Its primary focus is on the development of products related to human health and well-being. The company provides pharmaceuticals in immunology, cancer, neuroscience, infec …
  • Dominion Resources Inc:発電所・企業SWOT分析
    Dominion Resources Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • Matica Technologies AG:企業の戦略的SWOT分析
    Matica Technologies AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • GeoVax Labs Inc (GOVX)-製薬・医療分野:企業M&A・提携分析
    Summary GeoVax Labs Inc (GeoVax) is a clinical-stage biotechnology company, which develops human vaccines for diseases caused by HIV, cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company’s vaccine development programs focus o …
  • Cryo-Cell International Inc (CCEL):企業の財務・戦略的SWOT分析
    Summary Cryo-Cell International Inc (Cryo-Cell) is a cord blood bank service provider. The company offers biotechnology services, collection and preservation of umbilical cord blood stem cells for family use. It provides services such as cord blood banking, cord tissue banking, cord blood and tissue …
  • Photocure ASA (PHO):企業の財務・戦略的SWOT分析
    Photocure ASA (PHO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Pattern Energy Group Inc (PEGI):企業の財務・戦略的SWOT分析
    Pattern Energy Group Inc (PEGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • PeptiDream Inc (4587):企業の財務・戦略的SWOT分析
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produ …
  • Ra Medical Systems Inc (RMED):企業の製品パイプライン分析
    Summary Ra Medical Systems Inc (Ra Medical Systems) is a medical device company that develops, designs, and commercializes excimer laser systems for the treatment of cardiovascular and dermatologic diseases. The company’s technology provides operational versatility and dose customization. Its produc …
  • Shell Pakistan Ltd (SHEL):企業の財務・戦略的SWOT分析
    Summary Shell Pakistan Ltd (Shell Pakistan), a subsidiary of Royal Dutch Shell plc is an oil and gas company that markets petroleum products and compressed natural gas. The company operates through three segments such as retail, lubricants and aviation. It retail segment offers a range of fuels such …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆